Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 10% Improvement Relative Risk c19hcq.org Turrini et al. HCQ for COVID-19 LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 205 patients in Italy No significant difference in mortality Turrini et al., Vaccines, 10.3390/vaccines9060640 Favors HCQ Favors control
Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, Italy
Turrini et al., Vaccines, 10.3390/vaccines9060640
Turrini et al., Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como,.., Vaccines, 10.3390/vaccines9060640
Jun 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 205 patients in Italy, 160 treated with HCQ, showing lower mortality with treatment in multivariate analysis, but not reaching statistical significance.
risk of death, 9.8% lower, RR 0.90, p = 0.15, treatment 103 of 160 (64.4%), control 33 of 45 (73.3%), NNT 11, adjusted per study, odds ratio converted to relative risk, multivariate.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Turrini et al., 11 Jun 2021, retrospective, Italy, peer-reviewed, 16 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Article Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, Italy Mauro Turrini 1, * , Angelo Gardellini 1 , Livia Beretta 2 , Lucia Buzzi 3 , Stefano Ferrario 4 , Sabrina Vasile 5 , Raffaella Clerici 6 , Andrea Colzani 4 , Luigi Liparulo 7 , Giovanni Scognamiglio 8 , Gianni Imperiali 9 , Giovanni Corrado 10 , Antonello Strada 11 , Marco Galletti 12 , Nunzio Castiglione 13 and Claudio Zanon 13 1 2 3 4 5 6 7   8 9 Citation: Turrini, M.; Gardellini, A.; Beretta, L.; Buzzi, L.; Ferrario, S.; 10 Vasile, S.; Clerici, R.; Colzani, A.; 11 Liparulo, L.; Scognamiglio, G.; et al. Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, Italy. Vaccines 2021, 9, 640. https:// doi.org/10.3390/vaccines9060640 Academic Editors: Ralph A. Tripp, Steven B. Bradfute and Scott Anthony Received: 1 May 2021 Accepted: 8 June 2021 Published: 11 June 2021 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// 12 13 * Department of Medicine, Division of Hematology, Valduce Hospital, 22100 Como, Italy; agardellini@valduce.it Risk Management, Valduce Hospital, 22100 Como, Italy; lberetta@valduce.it Quality Management System, Valduce Hospital, 22100 Como, Italy; lbuzzi@valduce.it Department of Medicine, Division of Pneumology, Valduce Hospital, 22100 Como, Italy; sferrario@valduce.it (S.F.); acolzani@valduce.it (A.C.) Department of Mother and Child, Division of Paediatric and Neonatology, Infectious Diseases Consultant, Valduce Hospital, 22100 Como, Italy; svasile@valduce.it Department of Medicine, Division of Neurology, Valduce Hospital, 22100 Como, Italy; rclerici@valduce.it Department of Medicine, Division of Internal Medicine, Valduce Hospital, 22100 Como, Italy; lliparulo@valduce.it Department of Medicine, Division of Oncology, Valduce Hospital, 22100 Como, Italy; giosco@valduce.it Department of Medicine, Division of Gastroenterology, Valduce Hospital, 22100 Como, Italy; g.imperiali@libero.it Department of Medicine, Division of Cardiology, Valduce Hospital, 22100 Como, Italy; gcorrado@valduce.it Department of Emergency Medicine, Valduce Hospital, 22100 Como, Italy; astrada@valduce.it Department of Intensive Care Medicine, Valduce Hospital, 22100 Como, Italy; mgalletti@valduce.it Hospital Health Management, Valduce Hospital, 22100 Como, Italy; ncastiglione@valduce.it (N.C.); zanonclaudio762@gmail.com (C.Z.) Correspondence: mturrini@valduce.it; Tel.: +39-031324419 Abstract: The aim of this study is to explore risk factors for in-hospital mortality and describe the effectiveness of different treatment strategies of 205 laboratory-confirmed cases infected with SARSCoV-2 during the Lombardy outbreak. All patients received the best supportive care and specific interventions that included the main drugs being tested for repurposing to treat COVID-19, such as hydroxychloroquine, anticoagulation and antiviral drugs, steroids, and interleukin-6 pathway inhibitors. Clinical, laboratory, and treatment characteristics were analyzed with univariate and multivariate logistic regression methods to explore their impact on..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit